Summary
Jimmy Zhang is a biotech executive and founder with over two decades of cross-border experience spanning Big Pharma, venture investing, and hands-on startup leadership. He has led business development, licensing and transactions at J&J and Merck, built and financed gene and cell therapy ventures (raising >$64M), and served as Venture Partner at Lilly Asia Ventures and board director of multiple biotechs. Trained as a PhD under Nobel Laureates and an MBA from MIT Sloan, he blends rigorous scientific pedigree with strategic consulting discipline from McKinsey. Jimmy is known for closing complex technology and equity deals, building GMP manufacturing capabilities across the US and China, and translating academic IP into clinical programs. He mentors at QB3/Bakar Labs and in academia, uniquely combining investor, operator and teacher perspectives to help startups scale. A less obvious strength is his track record of orchestrating trilateral collaborations (e.g., CHOP, UPenn, CIRM/MOST) that bridge institutions, industry and cross-border funding.
10 years of coding experience
15 years of employment as a software developer
MBA, Management, MBA, Management at MIT Sloan School of Management
PhD, Biomedical Sciences, PhD, Biomedical Sciences at UT Southwestern Medical Center
Chinese, English